News/Insights

Attendance at JPM 2025 in San Francisco

Exciting times for the Echopoint Medical team at #JPM2025 in San Francisco!

We had the pleasure of attending both the RESI JPM Conference and the McDermott Forum, where we engaged in positive meetings and received fantastic feedback on our iKOr™ system. It’s incredibly rewarding to see the enthusiasm and interest from attendees, especially regarding the potential of iKOr™ to address inequities in women’s cardiac health.

Our mission has always been to make a real difference in the diagnosis and treatment of heart conditions, particularly in underserved areas like INOCA. The conversations we’ve had this week reaffirm our commitment to delivering innovation that truly matters.

A big thank you to everyone who took the time to meet with us and share their thoughts. Together, we can drive change and improve outcomes for women around the world.

Attendance at JPM 2025 in San Francisco

JPM 2026 – Coronary Microvascular Disease coming into focus

Echopoint Medical joins leading cardiovascular accelerator program

Exciting Times at LSI USA 2025 – Advancing Heart Health in Women

Visit of Tim van de Hoef to Echopoint’s offices

London, Feb 11, 2025 – Echopoint was honoured to welcome Dr. Tim van De Hoef, a renowned Interventional Cardiologist from the University Medical [...]

Closing the Women’s Health Gap: A Blueprint for Global Impact

The latest World Economic Forum report, in collaboration with the McKinsey Health Institute, highlights the urgent need to address inequities in women’s health. [...]

Attendance at JPM 2025 in San Francisco

Exciting times for the Echopoint Medical team at #JPM2025 in San Francisco! We had the pleasure of attending both the RESI JPM Conference [...]

Echopoint Medical Ltd Welcomes Nancy Briefs as Chair of the Board

Echopoint Medical Ltd is pleased to announce the appointment of Nancy Briefs as our new Chair of the Board. Nancy brings a wealth [...]

UCL Spinout Echopoint Medical Ltd Secures £4.2 Million in Series A Funding, Advancing FDA Approval Process for iKOr System

London, 20thth February 2024 Echopoint Medical, an innovative force in cardiovascular diagnostic technology and a spinout from UCL, announces a £4.2 million in Series [...]

Echopoint Medical starts its first in human study at Barts Heart Centre (London, UK).

This milestone was recognised by the Financial Times and with coverage by Clive Cookson.

Echopoint Medical obtain regulatory approval for a First-in-Human study in the United Kingdom from the Medicines and Healthcare products Regulatory Agency (MHRA)

Malcolm Finlay Presents at the Innovators Competition at EuroPCR (Paris)

Antony Odell presents at the Innovation Summit (Dublin)

Antony pitches at the LSX World Congress (London)

Adrien Desjardins awarded a Royal Society Fellowship spanning Echopoint and the University College London

Echopoint Medical receives ISO 13845 Certification

Malcolm presents at ICI: Innovation in Cardiovascular Intervention (Tel Aviv)

Echopoint are awarded a Smart Grant from Innovate UK

Echopoint Medical are awarded a Precision Medicine Award from Innovate UK

Echopoint Medical are awarded a Biomedical Catalyst Award

Echopoint Medical wins at the 2019 SEHTA MedTech Business Award

Echopoint Medical win the UCL Business Innovators Award